Survey of Osteoarthritis Real World Therapies (MK-0663-140) (SORT)

Organon

Status: Completed

Conditions: Osteoarthritis

Treatments: Drug: Standard of care for treatment of osteoarthritis (OA) of knee(s)

Study type: Observational

Funder types: Industry

Identifiers

NCT01294696

0663-140

Details and patient eligibility

About

This was a study to estimate the proportion of participants with osteoarthritis of the knee(s) who were treated with oral or topical analgesics for their symptoms, who did and did not report adequate pain relief at Baseline and to characterize their pain level over a 12-month follow-up period.

Enrollment: 1,261 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of primary osteoarthritis of the knee(s)
• Presently receiving prescribed oral or topical analgesics for a minimum duration of two weeks prior to enrollment

Exclusion criteria

• Arthritis other than primary osteoarthritis
• Treatment with disease-modifying antirheumatic drugs (DMARDS), methotrexate or biologics
• Subtotal or total joint replacement in the affected knee
• Chronic severe pain of other causes that in the opinion of the investigator may require long-term analgesia or confound the present study
• Currently enrolled in a clinical trial or who have participated in a clinical trial within the past 30 days

Trial design

1,261 participants in 1 patient group

All Enrolled Participants

Description:

All participants will be treated according to standard medical guidelines or usual clinical practice standards of the investigating physician.

Treatment:

Drug: Standard of care for treatment of osteoarthritis (OA) of knee(s)